To hear about similar clinical trials, please enter your email below
Trial Title:
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
NCT ID:
NCT06070285
Condition:
Recurrent Ovarian Cancer
Conditions: Official terms:
Ovarian Neoplasms
Carcinoma, Ovarian Epithelial
Recurrence
Conditions: Keywords:
Recurrent Ovarian Cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical trials, with a particular focus on recurrent ovarian cancer, play a crucial role
in assessing the safety and efficacy of novel treatments for this condition. These trials
serve as essential tools to determine whether new medications outperform traditional
therapies, providing substantial evidence to support their widespread adoption.
By actively participating in recurrent ovarian cancer observational study serves pivotal
role in expanding the boundaries of medical knowledge and advancing the quality of care
provided to those enduring the same condition.
Criteria for eligibility:
Study pop:
Patients with recurrent ovarian cancer who are actively considering enrolling in a
clinical trial for said condition, but have not yet completed enrollment and
randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Aged ≥ 18 years old
- Able to comprehend the investigational nature of the protocol and provide informed
consent
- Diagnosis of recurrent ovarian cancer
Exclusion Criteria:
- No diagnosis of recurrent ovarian cancer confirmed
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Gender:
Female
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
October 2024
Completion date:
October 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06070285
